…ncers. However, despite the high disease and economic burden of hepatocellular carcinoma (HCC) and the complex symptom profile during immunotherapy, the…
Hepatocellular carcinoma
This disease is selected. Its supporting articles are shown below.
Articles mentioning Hepatocellular carcinoma
253 articles · page 9 of 22…Background Hepatocellular carcinoma (HCC), one of the most prevalent cancers worldwide, has a high …
…us targeted therapy with or without immunotherapy. MVI-positive HCC derives added benefit from adjuvant tyrosine kinase inhibitors …
…Background Hepatocellular carcinoma (HCC) remains a leading cause of cancer mortality worldwide. Wh…
… carcinoma, metabolic dysfunction-associated steatohepatitis or hepatic fibrosis. Nevertheless, significant barriers prevent the widespread adop…
…Background Metabolic reprogramming is a hallmark of hepatocellular carcinoma (HCC), enabling rapid tumour growth and immune evasion. Protein…
…dal strategy can spatiotemporally reprogram the TME in advanced HCC with PVTT. This approach has the potential to effectively overc…
… issues regarding the implementation of non-invasive test-based hepatocellular carcinoma (HCC) surveillance in patients with metabolic dysfunction-assoc…
…imaging model (LFM) and a clinical-radiological model (CRM) for hepatocellular carcinoma treated with transarterial chemoembolisation (TACE).1 The multi…
…Introduction Hepatocellular carcinoma (HCC) recurs in most patients after curative treatment. Late re…
…Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and the t…
…SM) ≥20 kPa (or LSM ≥15 kPa in the two-step algorithm)—to guide hepatocellular carcinoma (HCC) surveillance in patients with metabolic dysfunction-assoc…